Baillie Gifford & Co’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-9,158,876
Closed -$79.4M 278
2025
Q1
$79.4M Sell
9,158,876
-590,127
-6% -$6.18M 0.07% 130
2024
Q4
$118M Sell
9,749,003
-1,478,216
-13% -$20.7M 0.09% 121
2024
Q3
$189M Sell
11,227,219
-353,767
-3% -$5.82M 0.14% 102
2024
Q2
$181M Sell
11,580,986
-208,535
-2% -$2.9M 0.14% 97
2024
Q1
$186M Buy
11,789,521
+3,502,807
+42% +$58.6M 0.14% 100
2023
Q4
$167M Buy
+8,286,714
New +$140M 0.13% 107

Other funds holding NEOG

Baillie Gifford & Co's NEOG Position: Q2 2025 in Review

Baillie Gifford & Co sold out of Neogen (NEOG) in Q2 2025, closing a stake of 9,158,876 shares — an estimated $79.4M sold.

Baillie Gifford & Co first reported a position in NEOG in Q4 2023 and held it in 6 quarters. The position peaked at $189M in Q3 2024. 317 funds tracked by Wall St. Rank hold NEOG as of Q2 2025.

  • Baillie Gifford & Co reported no remaining Neogen position as of Q2 2025 after selling out during the quarter.
  • Baillie Gifford & Co sold 9,158,876 Neogen shares in Q2 2025, an estimated $79.4M.
  • Baillie Gifford & Co first reported a position in Neogen in Q4 2023 and held it in 6 quarters.
  • Baillie Gifford & Co's Neogen position peaked at $189M in Q3 2024.
  • 317 funds tracked by Wall St. Rank held Neogen as of Q2 2025.

Based on Baillie Gifford & Co's 13F filing for Q2 2025, filed 6 Aug 2025.